Barriers to Uptake of Drug Resistant Tuberculosis (DRTB) services and Care in Nigeria: Lessons Learnt from Implementation of Community Management of DR TB Patients
Ogbuji Queen Chidinma, Ojo Ola Matthews, Osho Adewale John, Anozie Ijeoma Achu Etta Takim, Osinowo Kehinde
{"title":"Barriers to Uptake of Drug Resistant Tuberculosis (DRTB) services and Care in Nigeria: Lessons Learnt from Implementation of Community Management of DR TB Patients","authors":"Ogbuji Queen Chidinma, Ojo Ola Matthews, Osho Adewale John, Anozie Ijeoma Achu Etta Takim, Osinowo Kehinde","doi":"10.51505/ijmshr.2022.6408","DOIUrl":null,"url":null,"abstract":"Objectives: This article examines the barriers to uptake of DRTB baseline and follow-up tests for DRTB patients in Nigeria. Methodology: The study involved all the Local Government Areas (LGAs} in 35 Nigerian states and the FCT where community DRTB intervention is implemented. Purposeful sampling technique was employed and included all DRTB patients currently on treatment. Data collection was done using a structured questionnaire. The data analysis was done using SPSS version 22 for running the univariate analysis and reported in frequencies and percentages. Data were summarized using descriptive statistics, frequency distribution tables and presented in tables. Results: The finding showed that 55.9% of the patients had difficulty accessing the baseline investigation tests. 49% reported lack of transport fare while 47.4% reported that the lab facility where the baseline was conducted was too far from their homes. About 58.8% of the respondents stayed up to 1-2 weeks after diagnosis before having the baseline investigation tests done and 61.4% of the patients did not always have money to go for follow-up tests Conclusion: This study showed gap between diagnosis and enrolment on treatment of patient with drug resistant Tuberculosis in Nigeria due to challenges in accessing pre-requisite baseline investigation tests. This has potential to result to loss-to-follow-up. There is need for decentralization to facilities close to where patients reside and more social support to the patients to ensure that all diagnosed patients are enrolled on treatment.","PeriodicalId":285067,"journal":{"name":"International Journal of Medical Science and Health Research","volume":"128 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Medical Science and Health Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.51505/ijmshr.2022.6408","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: This article examines the barriers to uptake of DRTB baseline and follow-up tests for DRTB patients in Nigeria. Methodology: The study involved all the Local Government Areas (LGAs} in 35 Nigerian states and the FCT where community DRTB intervention is implemented. Purposeful sampling technique was employed and included all DRTB patients currently on treatment. Data collection was done using a structured questionnaire. The data analysis was done using SPSS version 22 for running the univariate analysis and reported in frequencies and percentages. Data were summarized using descriptive statistics, frequency distribution tables and presented in tables. Results: The finding showed that 55.9% of the patients had difficulty accessing the baseline investigation tests. 49% reported lack of transport fare while 47.4% reported that the lab facility where the baseline was conducted was too far from their homes. About 58.8% of the respondents stayed up to 1-2 weeks after diagnosis before having the baseline investigation tests done and 61.4% of the patients did not always have money to go for follow-up tests Conclusion: This study showed gap between diagnosis and enrolment on treatment of patient with drug resistant Tuberculosis in Nigeria due to challenges in accessing pre-requisite baseline investigation tests. This has potential to result to loss-to-follow-up. There is need for decentralization to facilities close to where patients reside and more social support to the patients to ensure that all diagnosed patients are enrolled on treatment.
目的:本文探讨了尼日利亚耐药结核病患者接受耐药结核病基线和随访检测的障碍。方法:该研究涉及尼日利亚35个州的所有地方政府地区和实施社区DRTB干预措施的FCT。采用有目的的抽样技术,纳入目前正在接受治疗的所有耐药结核病患者。数据收集采用结构化问卷。数据分析使用SPSS version 22进行单变量分析,并以频率和百分比报告。采用描述性统计、频率分布表和表格对数据进行汇总。结果:55.9%的患者难以获得基线调查测试。49%的人报告缺乏交通费用,47.4%的人报告进行基线的实验室设施离他们的家太远。约58.8%的答复者在诊断后1-2周后才进行基线调查测试,61.4%的患者并不总是有钱进行后续测试。结论:这项研究表明,由于在获得必要的基线调查测试方面存在挑战,尼日利亚耐药结核病患者的诊断和治疗登记之间存在差距。这有可能导致后续损失。有必要将权力下放到靠近患者居住地的设施,并向患者提供更多的社会支持,以确保所有确诊的患者都登记接受治疗。